Global eye care company Alcon last week debuted the iLux® MGD Treatment System to the Eye Care Professional (ECP) community at the SECO International 2019 annual meeting, which took place February 20-24 in New Orleans, LA. The device, which received approval from the Food and Drug Administration in December 2017, helps eye care professionals provide comprehensive, in-office treatment for their patients with dry eye disease. The launch was accompanied with an interactive booth experience and dozens of educational events and product innovations.
The innovative and personalized iLux® MGD Treatment System addresses Meibomian Gland Dysfunction (MGD), a leading cause of dry eye. Handheld and portable, the iLux® Device with Smart Tip Patient Interface enables ECPs to directly target a patient’s blocked Meibomian glands through the application of light-based heat and compression under direct visualization. The device expands the company’s current dry eye treatment offerings and allows practitioners to tailor treatment to the needs of each of their patients with dry eye disease in a matter of minutes.
Alcon has also teamed up with Microsoft and Elara Systems to create the new Multifocal Virtual Reality training module for ECPs, residents and students. This immersive, three-dimensional educational experience guides practitioners through the multifocal contact lens fitting process for presbyopic patients. The new training is part of the Alcon Experience Academy, which offers industry-leading face-to-face and virtual trainings and educational resources for all Eye Care Professionals. The training module has also debuted at the SECO 2019 meeting.
Read the full news release from Alcon.